Detalhe da pesquisa
1.
Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials
Int. j. cardiol;
300(1): 60-65, Jul, 2019. tabela, gráfico
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1103433
2.
First report of edge vascular response at 12 months of Magmaris, a second-generation drug-eluting resorbable magnesium scaffold, assessed by grayscale intravascular ultrasound, virtual histology, and optical coherence tomography. A biosolve-II trial sub-study
Cardiovasc Revasc Med;
20(5): 392-398, May 2019. ilus, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1006900